Marshall Wace’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-23,978
Closed -$419K 4430
2021
Q3
$419K Sell
23,978
-4,135
-15% -$74.6K ﹤0.01% 2483
2021
Q2
$573K Buy
+28,113
New +$566K ﹤0.01% 2072
2021
Q1
Sell
-594
Closed -$37K 2969
2020
Q4
$37K Buy
+594
New +$34.1K ﹤0.01% 1820
2019
Q1
Sell
-2,393
Closed -$113K 2133
2018
Q4
$113K Buy
2,393
+1,068
+81% +$123K ﹤0.01% 1348
2018
Q3
$200K Buy
+1,325
New +$189K ﹤0.01% 1071
2016
Q1
Sell
-5,661
Closed -$2.38M 1225
2015
Q4
$2.38M Buy
+5,661
New +$2.53M 0.02% 527
2014
Q2
Sell
-4,212
Closed -$2.33M 1105
2014
Q1
$2.33M Buy
+4,212
New +$2.88M 0.04% 332

Other funds holding ACGN

Marshall Wace's ACGN Position: Q4 2021 in Review

Marshall Wace sold out of Aceragen Inc (ACGN) in Q4 2021, closing a stake of 23,978 shares — an estimated $419K sold.

Marshall Wace first reported a position in ACGN in Q1 2014 and held it in 7 quarters. The position peaked at $2.38M in Q4 2015. 34 funds tracked by Wall St. Rank hold ACGN as of Q4 2021.

  • Marshall Wace reported no remaining Aceragen Inc position as of Q4 2021 after selling out during the quarter.
  • Marshall Wace sold 23,978 Aceragen Inc shares in Q4 2021, an estimated $419K.
  • Marshall Wace first reported a position in Aceragen Inc in Q1 2014 and held it in 7 quarters.
  • Marshall Wace's Aceragen Inc position peaked at $2.38M in Q4 2015.
  • 34 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.